Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
KPTI
KPTI
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
KPTI News
Karyopharm to Speak at 2026 Jefferies Global Healthcare Conference
3d ago
PRnewswire
Karyopharm Therapeutics Q1 2026 Earnings Call Insights
May 14 2026
seekingalpha
Karyopharm Q1 Earnings Beat Expectations
May 14 2026
seekingalpha
Karyopharm Reports Q1 2026 Financial Results and Clinical Progress
May 14 2026
PRnewswire
Karyopharm Therapeutics Set to Announce Q1 Earnings Results
May 13 2026
seekingalpha
Karyopharm to Participate in Investor Conferences
May 12 2026
PRnewswire
Karyopharm to Report Q1 2026 Financial Results on May 14
May 07 2026
PRnewswire
Karyopharm to Present SENTRY Trial Results at ASCO 2026
Apr 21 2026
PRnewswire
Biotech Landscape Update: Regulatory Approvals and Mergers
Mar 27 2026
NASDAQ.COM
KPTI Shares Drop in Pre-Market Trading Despite Karyopharm's Myelofibrosis Treatment Achieving Key Goal — Retail Investors Skeptical of FDA Approval
Mar 24 2026
stocktwits
Karyopharm Seeks Label Expansion for Xpovio After Positive Trial Results
Mar 24 2026
seekingalpha
Karyopharm Therapeutics Secures $30M Private Placement
Mar 24 2026
seekingalpha
Karyopharm Reports Significant Results from SENTRY Trial for Myelofibrosis
Mar 24 2026
PRnewswire
Karyopharm Secures $30 Million in Private Placement Financing
Mar 24 2026
PRnewswire
Karyopharm Secures $30 Million in Private Placement Financing
Mar 24 2026
Newsfilter
Wall Street Analysts Adjust Ratings on Key Stocks
Mar 10 2026
Benzinga
Show More News
